UY29776A1 - Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen - Google Patents

Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen

Info

Publication number
UY29776A1
UY29776A1 UY29776A UY29776A UY29776A1 UY 29776 A1 UY29776 A1 UY 29776A1 UY 29776 A UY29776 A UY 29776A UY 29776 A UY29776 A UY 29776A UY 29776 A1 UY29776 A1 UY 29776A1
Authority
UY
Uruguay
Prior art keywords
timoregulating
agomelatin
agent
pharmaceutical compositions
compositions containing
Prior art date
Application number
UY29776A
Other languages
English (en)
Inventor
Christian De Bodinat
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36190792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29776(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY29776A1 publication Critical patent/UY29776A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/08Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/10Antiepileptics; Anticonvulsants for petit-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/12Antiepileptics; Anticonvulsants for grand-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

NUEVA ASOCIACION ENTRE LA AGOMELATINA Y UN AGENTE TIMOREGULADOR Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN.
UY29776A 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen UY29776A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509208A FR2890563B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY29776A1 true UY29776A1 (es) 2006-11-30

Family

ID=36190792

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29776A UY29776A1 (es) 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen

Country Status (38)

Country Link
US (1) US7902180B2 (es)
EP (2) EP1762238B1 (es)
JP (1) JP2007077149A (es)
KR (2) KR20070029607A (es)
CN (1) CN1927194A (es)
AP (1) AP3045A (es)
AR (1) AR055418A1 (es)
AT (1) ATE519482T1 (es)
AU (1) AU2006209371B2 (es)
BR (1) BRPI0603767A (es)
CA (1) CA2558764C (es)
CY (1) CY1112223T1 (es)
DK (1) DK1762238T3 (es)
EA (1) EA014381B1 (es)
ES (1) ES2371482T3 (es)
FR (1) FR2890563B1 (es)
GE (1) GEP20094741B (es)
GT (1) GT200600410A (es)
HR (1) HRP20110749T1 (es)
JO (1) JO2746B1 (es)
MA (1) MA28504B1 (es)
ME (1) ME01964B (es)
MX (1) MXPA06010234A (es)
MY (1) MY162318A (es)
NO (1) NO338079B1 (es)
NZ (1) NZ549727A (es)
PE (1) PE20070613A1 (es)
PL (1) PL1762238T3 (es)
PT (1) PT1762238E (es)
RS (1) RS52003B (es)
SA (1) SA110320045B1 (es)
SG (1) SG131029A1 (es)
SI (1) SI1762238T1 (es)
TW (1) TWI369980B (es)
UA (1) UA83541C2 (es)
UY (1) UY29776A1 (es)
WO (1) WO2007028903A1 (es)
ZA (1) ZA200607532B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CZ20013786A3 (cs) * 1999-04-29 2002-02-13 Merck Patent Gmbh Inhibitory glycinového ątěpicího systému jako moľná antipsychotika
CN100525761C (zh) * 1999-12-01 2009-08-12 Ucb公司 用于治疗cns疾病的吡咯烷乙酰胺衍生物或者其组合物
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires

Also Published As

Publication number Publication date
US20070066689A1 (en) 2007-03-22
SG131029A1 (en) 2007-04-26
PL1762238T3 (pl) 2011-12-30
EP1762238A1 (fr) 2007-03-14
JP2007077149A (ja) 2007-03-29
PE20070613A1 (es) 2007-07-30
EA014381B1 (ru) 2010-10-29
AR055418A1 (es) 2007-08-22
MA28504B1 (fr) 2007-04-03
MXPA06010234A (es) 2007-03-08
AU2006209371A1 (en) 2007-03-29
SI1762238T1 (sl) 2011-10-28
FR2890563A1 (fr) 2007-03-16
UA83541C2 (uk) 2008-07-25
NO338079B1 (no) 2016-07-25
ATE519482T1 (de) 2011-08-15
NO20064049L (no) 2007-03-12
EP1762238B1 (fr) 2011-08-10
PT1762238E (pt) 2011-09-01
WO2007028903A1 (fr) 2007-03-15
AP3045A (en) 2014-11-30
CN1927194A (zh) 2007-03-14
GT200600410A (es) 2007-05-21
CY1112223T1 (el) 2015-12-09
AP2008004380A0 (en) 2008-04-30
ES2371482T3 (es) 2012-01-03
TW200800860A (en) 2008-01-01
RS52003B (en) 2012-04-30
JO2746B1 (en) 2014-03-15
SA110320045B1 (ar) 2014-01-29
CA2558764A1 (fr) 2007-03-09
KR20090056949A (ko) 2009-06-03
FR2890563B1 (fr) 2007-10-19
CA2558764C (fr) 2013-01-08
TWI369980B (en) 2012-08-11
AU2006209371B2 (en) 2012-02-02
ME01964B (me) 2012-04-30
BRPI0603767A (pt) 2007-08-14
DK1762238T3 (da) 2011-11-07
MY162318A (en) 2017-05-31
HRP20110749T1 (hr) 2011-11-30
EP2301527A1 (fr) 2011-03-30
US7902180B2 (en) 2011-03-08
ZA200607532B (en) 2008-05-28
KR20070029607A (ko) 2007-03-14
EA200601450A1 (ru) 2007-04-27
NZ549727A (en) 2008-03-28
GEP20094741B (en) 2009-07-27

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DOP2019000185A (es) Una formulación sólida de dosificación farmacéutica
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
NO20080023L (no) Magnetoreologisk vaeske
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
UY28348A1 (es) Compuestos novedosos
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
PA8691901A1 (es) Composicion farmaceutica solida que comprende 1-(4-cloro-anilino)-4-(4-piridil-metil)-ftalazina y un modificador del ph
BRPI0619911A2 (pt) composto, pró-droga, agente farmacêutico, e, uso do composto
AR103567A2 (es) Comprimidos que contienen saborizantes y/o aromatizantes
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
BRPI0608287A2 (pt) agente endoparasiticida
ECSP099386A (es) Agentes para combatir parásitos en animales
DE60310936D1 (de) Riechstoffzusammensetzung
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
ITMI20030385A1 (it) Composizione cosmetica comprendente poliisoprene.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180528